ID: ALA5272895

Max Phase: Preclinical

Molecular Formula: C16H12N2S2

Molecular Weight: 296.42

Associated Items:

Representations

Canonical SMILES:  S=C=Nc1ccc(CCc2ccc(N=C=S)cc2)cc1

Standard InChI:  InChI=1S/C16H12N2S2/c19-11-17-15-7-3-13(4-8-15)1-2-14-5-9-16(10-6-14)18-12-20/h3-10H,1-2H2

Standard InChI Key:  KGPFLJVFCCOOEO-UHFFFAOYSA-N

Associated Targets(Human)

Pyrimidinergic receptor P2Y6 717 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.42Molecular Weight (Monoisotopic): 296.0442AlogP: 4.94#Rotatable Bonds: 5
Polar Surface Area: 24.72Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 6.55CX LogD: 6.55
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.58Np Likeness Score: -0.33

References

1. Conroy S, Kindon N, Kellam B, Stocks MJ..  (2016)  Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.,  59  (22): [PMID:27413802] [10.1021/acs.jmedchem.5b01972]

Source